Bioverativ and Bicycle form research collaboration in hemophilia and sickle cell disease Sep. 6, 2017 No Comments
FDA gives rare pediatric disease designation to Global Blood Therapeutics' GBT-440 Sep. 6, 2017 No Comments
Bioverativ and Invicro form imaging collaboration to improve joint disease management in hemophilia Aug. 25, 2017 No Comments
Bristol-Myers Squibb describes discovery of antithrombotic macrocyclic FXIa inhibitors Aug. 25, 2017 No Comments
RSS